Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Allan W Cripps

Showing results (11-20 of 125) with videos related to

Pageof 13
Sort By:
Pneumonia (Nathan Qld.)|August 30, 2019
Delivering vaccines for the prevention of pneumonia - programmatic and financial issuesDiana C Otczyk, Allan W Cripps
Pneumonia (Nathan Qld.)|August 30, 2019
Vaccination for the control of childhood bacterial pneumonia - <i>Haemophilus influenzae</i> type b and pneumococcal vaccinesDiana C Otczyk, Allan W Cripps
International Journal of Chronic Obstructive Pulmonary Disease|November 8, 2019
An Oral Whole-Cell Killed Nontypeable <i>Haemophilus influenzae</i> Immunotherapeutic For The Prevention Of Acute Exacerbations Of Chronic Airway DiseaseRobert L Clancy, Allan W Cripps
Vaccine|November 18, 2006
Comparison of mucosal and parenteral immunisation in two animal models of pneumococcal infection: otitis media and acute pneumoniaAllan W Cripps, Jennelle M Kyd
Human Vaccines|December 15, 2010
Mucosal immunization: a realistic alternativeDiana C Otczyk, Allan W Cripps
Vaccine|May 16, 2019
Retrospective cost-effectiveness of the 23-valent pneumococcal polysaccharide vaccination program in AustraliaPaul Van Buynder, Allan W Cripps
Vaccine|October 15, 2008
Functional differences between M cells and enterocytes in sampling luminal antigensJennelle M Kyd, Allan W Cripps
Human Vaccines & Immunotherapeutics|June 21, 2013
Passive immunization for the public health control of communicable diseases: current status in four high-income countries and where to nextMegan K Young, Allan W Cripps
The New England Journal of Medicine|August 23, 2013
Enteropathogens and chronic illness in returning travelersAllen G P Ross, Allan W Cripps
Current Opinion in Immunology|August 17, 2002
Challenges for the development of vaccines against Haemophilus influenzae and Neisseria meningitidisAllan W Cripps, Ruth Foxwell, Jennelle Kyd
Pageof 13

Showing results (11-20 of 125) with videos related to

Sort By:
Pageof 13
Pneumonia (Nathan Qld.)|August 30, 2019
Delivering vaccines for the prevention of pneumonia - programmatic and financial issuesDiana C Otczyk, Allan W Cripps
Pneumonia (Nathan Qld.)|August 30, 2019
Vaccination for the control of childhood bacterial pneumonia - <i>Haemophilus influenzae</i> type b and pneumococcal vaccinesDiana C Otczyk, Allan W Cripps
International Journal of Chronic Obstructive Pulmonary Disease|November 8, 2019
An Oral Whole-Cell Killed Nontypeable <i>Haemophilus influenzae</i> Immunotherapeutic For The Prevention Of Acute Exacerbations Of Chronic Airway DiseaseRobert L Clancy, Allan W Cripps
Vaccine|November 18, 2006
Comparison of mucosal and parenteral immunisation in two animal models of pneumococcal infection: otitis media and acute pneumoniaAllan W Cripps, Jennelle M Kyd
Human Vaccines|December 15, 2010
Mucosal immunization: a realistic alternativeDiana C Otczyk, Allan W Cripps
Vaccine|May 16, 2019
Retrospective cost-effectiveness of the 23-valent pneumococcal polysaccharide vaccination program in AustraliaPaul Van Buynder, Allan W Cripps
Vaccine|October 15, 2008
Functional differences between M cells and enterocytes in sampling luminal antigensJennelle M Kyd, Allan W Cripps
Human Vaccines & Immunotherapeutics|June 21, 2013
Passive immunization for the public health control of communicable diseases: current status in four high-income countries and where to nextMegan K Young, Allan W Cripps
The New England Journal of Medicine|August 23, 2013
Enteropathogens and chronic illness in returning travelersAllen G P Ross, Allan W Cripps
Current Opinion in Immunology|August 17, 2002
Challenges for the development of vaccines against Haemophilus influenzae and Neisseria meningitidisAllan W Cripps, Ruth Foxwell, Jennelle Kyd
Pageof 13